Boris Negrutskii- Department of Structural and Functional Proteomics, Institute of Molecular Biology and Genetics, National Academy of Sciences, Kyiv, Ukraine
The human translation machinery includes three types of supramolecular complexes involved in elongation of the polypeptide chain: the ribosome, complex of elongation factors eEF1B and multienzyme aminoacyl-tRNA synthetase complex. Of the above, eEF1B is the least investigated assembly. Recently, a number of studies provided some insights into the structure of different eEF1B subunits and changes in their expression in cancer and other diseases. There is increasing agreement that possible disease-related functions of eEF1B are not necessarily related to its role in translation. This mini-review focuses on structural and functional features of the eEF1B complex while paying special attention to possible non-canonical functions of its subunits in cancer cells.
Introduction
Several comprehensive reviews describing the basics of eEF1B structure and function have been published (see, for example, Le Sourd et al., 2006; Sasikumar et al., 2012). This mini-review summarizes novel structural, functional and expression data and presents recent information about possible cancer-related links of eEF1B subunits. Special attention is paid to newly emerging questions such as how stable the complex is in cancer tissues and how non-canonical involvements of its individual subunits are related to their intracellular localization. I regret that some important features of eEF1B remained undescribed due to space constrains.
Structural Insights
From the moment of its discovery, the eEF1B complex was considered as a stable unit which is essential for peptide elongation on the 80S ribosome. The human complex comprises three subunits: eEF1Bα (EEF1B2), eEF1Bβ (EEF1D), and eEF1Bγ (EEF1G), according to established nomenclature (IUBMB, 1996).
eEF1Bα is a non-globular protein which shows a noticeably extended shape in solution (Trosiuk et al., 2016). The C-terminal part of eEF1Bα executes nucleotide exchange while the N-terminal fragment connects the protein with the eEF1Bγ subunit. The N-terminal part of eEF1Bα plays an autoinhibitory role, while the presence of eEF1Bγ stimulates eEF1Bα-mediated nucleotide exchange (Trosiuk et al., 2016). The NMR-derived structure of the part of the eEF1Bα C-terminal domain is known (Pérez et al., 1999).
eEF1Bβ and eEF1Bα have similar domain structure. The C-terminal part of eEF1Bβ is highly homologous to the C-terminal domain of eEF1Bα, while the N-terminal fragment has the unique amino acid sequence, a part of which is a leucine-zipper structure responsible for oligomerization of eEF1Bβ (Bondarchuk et al., 2016). The very N-terminal fragment (1-77 amino acid residues) binds eEF1Bγ and, possibly, other proteins (Bondarchuk et al., 2019), however, we cannot exclude at present that the remaining part of the eEF1Bβ N-terminal domain is also involved in eEF1Bγ binding. This domain shows a dynamic spatial organization provided by α-helical segments linked by flexible linkers (Bondarchuk et al., 2019). The NMR-derived structure of the eEF1Bβ C-terminal fragment is known (Wu et al., 2016).
eEF1Bγ has no nucleotide exchange activity while playing instead a scaffold role in the complex as it hosts eEF1Bα and eEF1Bβ. Structural investigation of this subunit is complicated by its high tendency to aggregate (Sheu and Traugh, 1997, Kamiie et al., 2003). The NMR-derived structure of the 19 kDa C-terminal fragment of human protein (Vanwetswinkel et al., 2003) and crystal structure of the N-terminal domain of yeast protein (Jeppesen et al., 2003) are known.
Of note, unpublished structures of the complex of the eEF1Bα N-terminal domain and eEF1Bγ N-terminal domain and of the complex of the eEF1Bγ N-terminal domain and eEF1Bβ N-terminal domain are available in PDB (5DQS and 5JPO, correspondingly).
Functional Insights
Translation Functions
To date, the only established function of the eEF1B complex is to catalyze nucleotide exchange in another elongation factor, eEF1A, which supplies the ribosomes with aminoacyl-tRNAs. Both eEF1Bα and eEF1Bβ possess the nucleotide exchange activity. Importantly, different tissue-specific isoforms of eEF1A showed different eEF1Bα-dependence in vitro, namely, eEF1A2 rather than eEF1A1 strongly needed eEF1Bα for nucleotide exchange (Trosiuk et al., 2016). No corresponding information about eEF1Bβ is available. Deletion of the yeast eEF1Bγ gene induced increased misreading of near-cognate codons and decreased misreading of non-cognate codons (Plant et al., 2007). Interestingly, the yeast eEF1B complex was suggested to serve as an exchange agent for translation termination factor eRF3 (Valouev et al., 2009).
Non-canonical Functions
Beyond translation, subunits of eEF1B may be involved in many different processes, including cell cycle control, cytoskeleton regulation, and stress response, as summarized in Sasikumar et al. (2012). This section is focused on new non-canonical links of eEF1B revealed by a proteomic approach. Post-translational modification-related regulation of eEF1B subunits is not described here in full due to space constrains.
eEF1Bα
There is not too much data on non-canonical functions of eEF1Bα. This protein interacts with nuclear/cytoplasmic prolyl-isomerase FKBP25 (FKBP3) (Galat et al., 2014), which is a nucleic acid binding protein involved in both repair of DNA double-strand breaks (Dilworth et al., 2019) and microtubule polymerization (Dilworth et al., 2018). Depletion of nucleoside diphosphate kinase A (NME1) lead to a redistribution of eEF1Bα from the cytoplasm to the endoplasmic reticulum fraction in mouse liver (Bruneel et al., 2011). Importantly, nucleoside diphosphate kinase A can be transferred to the nucleus where it promotes the non-homologous end joining of the DNA double-strand breaks (Xue et al., 2019) and takes part in transcription (Puts et al., 2018).
The N-terminal fragment of eEF1Bα was reportedly secreted from mouse astrocytes upon stimulation of a Ca2+ increase by bradykinin treatment (Yin et al., 2012) though there was no explanation for the phenomenon.
eEF1Bβ
Some non-canonical involvements of eEF1Bβ in cell functioning are predicted. eEF1Bβ is a potential substrate of sucrose non-fermenting related kinase (SNRK) which controls adipose inflammation and energy homeostasis (Li et al., 2018). Importantly, knocking down eEF1Bβ expression in adipocytes induced inflammation (Li et al., 2018). Decreased expression of eEF1Bβ was detected during inflammation in lipid A-treated mouse epithelial cells (Takano et al., 2016).
eEF1Bβ inhibited auto-ubiquitination and degradation of E3 ubiquitin ligase (SIAH-1) (Wu et al., 2011). There was 3-fold increase in the amount of eEF1Bβ in pancreas of diabetic rats (Jiang et al., 2011). Upregulation of eEF1Bβ was reported in lungs of chronic hypoxic rats with pulmonary hypertension. Peculiarly, eEF1Bβ was heavily stained in the apical region of the epithelium in bronchioles, as well as in lymphocytes and macrophages interstitially dispersed in the epithelium (Østergaard et al., 2011).
eEF1Bβ was markedly decreased in senescent human fetal lung diploid fibroblasts cells, while treatment of these cells with a putative anti-aging agent caused an opposite effect (Xing et al., 2018). Similar influence of senescence on eEF1Bα (Byun et al., 2009) and eEF1Bβ (Takano et al., 2016), as well as on eEF1A1 (Byun et al., 2009) apparently reflects the global inhibition of protein synthesis during aging which supposedly occurs due to suppression of the whole eEF1B complex. Thus, an effect of senescence on eEF1B canonical function is also possible.
eEF1Bγ
The eEF1Bγ subunit shows a large variety of prospective non-canonical functions. A high in unsaturated fatty acids diet during gestation and lactation caused more than 5-fold eEF1Bγ increase in neonatal offspring liver in rats (Novak et al., 2009). eEF1Bγ was decreased in human myometrium after exogenous oxytocin administration while a reciprocal effect was observed upon administration of an oxytocin antagonist (de Wit et al., 2010).
Yeast eEF1Bγ and not the eEF1Bγ-eEF1Bα complex were supposedly involved to the retrograde Golgi to ER transport (Esposito and Kinzy, 2010). In other fungi, Aspergillus fumigatus, deletion of eEF1Bγ was associated with changes in oxidative stress and actin cytoskeleton organization (O’Keeffe et al., 2013). The gills from Atlantic halibut exposed to water containing high CO2 concentration showed upregulation of eEF1Bγ (Bresolin de Souza et al., 2014).
eEF1Bγ was one of the candidates to participate in loading of microRNAs into extracellular vesicles that may be needed to preserve microRNAs and transfer them to extracellular fluid (Hagiwara et al., 2015). eEF1Bγ interacted with components of DNA damage response machinery (Pisani et al., 2016). Yeast eEF1Bγ was found in stress granules upon heat shock (Grousl et al., 2013; Cherkasov et al., 2015). Interestingly, upon heat stress of yeast, all subunits of the eEF1B complex aggregate quickly and synchronously, contrary to eEF1A (Wallace et al., 2015). eEF1Bγ was identified as a member of the pre-mRNA 3′ end cleavage complex (Shi et al., 2009).
Oncogene-induced senescence in primary human fibroblasts caused a marked (more than 9-fold) increase in ubiquitination of eEF1Bγ. Peculiarly, no changes in ubiquitination of other subunits of eEF1B were found, while eEF1A, several aminoacyl-tRNA synthetases and translation initiation factors were also hyper ubiqiutinated (Bengsch et al., 2015). It should be noted, however, that mono- and polyubiquitination of eEF1Bγ were not differentiated in this case. eEF1Bγ was reported to positively affect K63-linked polyubiquitination of mitochondrial antiviral-signaling protein (MAVS) and negatively influence its K48-linked polyubiquitination resulting in the increased abundance of this antiviral protein (Liu et al., 2014).
An EEF1G– anaplastic lymphoma kinase (ALK) gene fusion was recently found in two pediatric patients with anaplastic large cell lymphoma (Palacios et al., 2017). In the context of the review, it is important that a fusion of the eEF1Bγ N-terminal domain provided exclusively cytoplasmic localization of the fusion protein (Ceccon et al., 2016) suggesting that the N-terminal domain of eEF1Bγ could not possibly be related to nuclear localization of eEF1Bγ alone.
Drosophila eEF1Bγ is a substrate of LAMMER kinase (DOA) and can be phosphorylated by human kinase LAMMER/CLK2 (CLK2) as well (Fan et al., 2010). Importantly, DOA kinase and eEF1Bγ negatively regulated motor-mediated transport of membrane organelles along microtubules depending on the phosphorylation of Ser 294 in eEF1Bγ (Serpinskaya et al., 2014).
eEF1B Proteins in Cancer
The levels of mRNA and a protein coded by this mRNA do not often correlate (Liu et al., 2016) which is valid for eEF1B subunits as well (Veremieva et al., 2011, 2014; Flores et al., 2016). This mini-review is focused on eEF1B proteins, therefore cancer-related changes in the levels of corresponding mRNAs are not considered here, although such changes may be of marker/prognostic importance (Hassan et al., 2018; Biterge-Sut, 2019). It is noteworthy that the data described in this section may be related to both canonical and non-canonical functioning of eEF1B subunits.
Not too much information is available on eEF1Bα association with cancer. Increased expression of eEF1Bα was reported as a negative prognosis marker in stomach cancer (Jia et al., 2018). Besides, ionizing radiation-induced senescence of breast cancer, lung cancer and colon cancer cell lines was accompanied by a significant decrease in eEF1Bα (Byun et al., 2009).
eEF1Bβ was long known as a cadmium-induced proto-oncogene (Joseph et al., 2002; Lei et al., 2002; Lei et al., 2010). Recently, eEF1Bβ was proposed as a blood marker for cadmium exposure (Lu et al., 2013). This protein was upregulated in the metastatic canine mammary carcinoma (Klopfleisch et al., 2010) and human oral squamous cell carcinoma (Flores et al., 2016) tissues, as well as in 5-fluorouracil-resistant human breast cancer cells (Zheng et al., 2010). Interestingly, knocking down of eEF1Bβ mRNA was accompanied by the opposite effects on the proliferation and epithelial mesenchymal transition (EMT)/invasion capabilities of squamous cell carcinoma cells (Flores et al., 2016). eEF1Bβ was upregulated in osteosarcoma and suggested to play a tumor-promoting role by facilitating the Akt-mTOR and Akt-Bad signaling pathways (Cheng et al., 2018).
The level of eEF1Bγ was increased in oral squamous cell carcinoma (Flores et al., 2016) and hepatic metastatic colorectal cancer (Yang et al., 2019). eEF1Bγ was downregulated in HepG2 cells treated with Nomura’s jellyfish venom used as an anti-cancer drug (Choudhary et al., 2018). Also, the protein was essentially decreased in cervical cancer specimens taken from patients after treatment with paclitaxel and cisplatin (Liu et al., 2011). eEF1Bγ may be an urine marker of bladder cancer (Chen et al., 2009). Interestingly, eEF1Bγ was 3-fold decreased in benign pleomorphic adenoma of the human parotid gland (Mutlu et al., 2017).
Complex Matter
One may notice that cancer-related changes of individual eEF1B subunits were observed far more often than corresponding changes of all subunits together. It raised a question whether malignant tumors induce deregulation of individual subunits rather than the whole eEF1B complex?
An attempt to meet this challenge was undertaken in series of papers where cancer-related changes in the level of all three eEF1B subunits were analyzed simultaneously in the same tissue samples (Veremieva et al., 2011, 2014). More than two-fold upregulation of at least one eEF1B subunit was observed in 72% of 25 cardioesophageal cancer samples. The simultaneous increase in the level of all three eEF1B subunits was observed in the one, simultaneous upregulation of eEF1Bα and eEF1Bβ was observed in two cases and simultaneous upregulation of eEF1Bβ and eEF1Bγ was found in four cases while no correlated increase of eEF1Bα and eEF1Bγ was detected (Veremieva et al., 2011). More than two-fold rise in the level of at least one eEF1B subunit was observed in 52% of 25 lung carcinoma samples. Again, the simultaneous increase in the level of all three eEF1B subunits was observed in one case, simultaneous upregulation of eEF1Bα and eEF1Bβ was also found in one case, simultaneous upregulation of eEF1Bβ and eEF1Bγ was observed in five cases while no correlated elevation of eEF1Bα and eEF1Bγ was found (Veremieva et al., 2014). The authors concluded that cancer-related upregulation of individual subunits rather than the whole eEF1B complex takes place in both cancers. Interestingly, the observed trend of coordinated up-regulation of eEF1Bβ and eEF1Bγ was spotted also in oral squamous cell carcinoma (Flores et al., 2016). It is interesting that eEF1Bβ and eEF1Bγ showed also a parallel increase in the prenatal as compared to postnatal expression levels in mice brain and liver (Cao et al., 2014). Further experiments should reveal if these correlative changes reflect the formation in vivo of a stable complex eEF1Bβ-eEF1Bγ.
Are Non-Canonical Functions of eEF1B Subunits Associated With Their Intracellular Localization?
Non-canonical functioning of eEF1B and/or its subunits is not yet attributed to specific cellular compartments. As translation occurs in the cytoplasm then the cytoplasmic localization of eEF1B is obvious. However, signs of the nuclear localization of eEF1B subunits were displayed in the normal (Drosophila embryos, human cardioesophageal junction, human lung) and cancer (cardioesophageal carcinoma, lung cancer, oral squamous cell carcinoma) tissues as well as in lung adenocarcinoma cells A549 (Fan et al., 2010; Veremieva et al., 2011; Veremieva et al., 2014; Flores et al., 2016). In an attempt to attribute possible non-canonical eEF1B functions to the specific cellular compartments the partners of eEF1Bβ and eEF1Bγ in the cytoplasm and nucleus of human lung carcinoma cells were identified experimentally and analyzed by several bioinformatics approaches (Kapustian et al., 2016, 2017, 2018, 2019). Cytoplasmic eEF1Bβ was predicted to be involved into four protein networks representing cell cycle regulation, DNA replication and repair, chromatin remodeling and chaperoning machinery (Kapustian et al., 2016). Nuclear eEF1Bβ interacted with proteins involved into RNA transcription and splicing, microRNA turnover, degradation of mRNA and proteins, DNA damage response. It could be also involved into adipose tissue biology and EMT (Kapustian et al., 2017). Cytoplasmic eEF1Bγ could participate in mRNA splicing and processing, nucleosome remodeling, cell cycle regulation, viral RNA transcription, oxidative stress response (Kapustian et al., 2018). Nuclear eEF1Bγ supposedly took part in splicing of pre-mRNA and regulation of mRNA stability, cytoskeleton-membrane linking and cellular trafficking (Kapustian et al., 2019).
One should mention that the co-immunoprecipitation data are not sufficient to provide an explicit evidence for an involvement of eEF1B subunits to one or the other process. However, analysis of these data is significant in that it provides a ground to develop the future direction of eEF1B research.
The Table 1 summarizes potential involvements of differently located eEF1B subunits in different cellular processes. No exclusive function can be attributed to cytoplasmic eEF1Bβ, while the only nucleus-localized eEF1Bβ may take part in adipose tissue biology (Kapustian et al., 2017). Both cytoplasmic and nuclear eEF1Bβ may be involved in EMT (Kapustian et al., 2016, 2017). The only cytoplasmic eEF1Bγ may participate in oxidative stress response (Kapustian et al., 2018). Taking into account the above-mentioned trends toward the coordinated upregulation of eEF1Bβ and eEF1Bγ in human cancer tissues it would be interesting to decipher the processes in which these subunits may be involved in concert. For the cytoplasmic fraction, those are, surprisingly, chromatin/nucleosome remodeling and cell cycle regulation (Kapustian et al., 2016, 2018) while for the nuclear fraction it is regulation of the mRNA stability and degradation (Kapustian et al., 2017, 2019). One should mention, however, that mixed intracellular localization is characteristic for components of these processes in cell. Besides, a number of processes may involve both cyto- and nucleo-localized eEF1Bβ and eEF1Bγ; these are microRNA turnover, cytoskeleton-membrane linking, cellular trafficking, mRNA transcription and splicing (Kapustian et al., 2016, 2017, 2018, 2019). This apparently reflects cyto-nucleo shuttling of subunits involved into these processes.
Table 1. Possible non-translational involvements of eEF1B subunits.
DNA repair may implicate both eEF1Bβ and eEF1Bα(Bruneel et al., 2011; Galat et al., 2014; Kapustian et al., 2016; Kapustian et al., 2017). This suggests an involvement of the whole eEF1B complex, as these subunits interact with each other via eEF1Bγ.
The viral infection-related functions of the eEF1B complex well described in Li et al. (2013) are not a subject of this mini-review, though some virus-related partners of eEF1B subunits were found in the cytoplasmic and nuclear fractions of lung carcinoma cells (Kapustian et al., 2017; Kapustian et al., 2018; Kapustian et al., 2019).
Surprisingly, a number of potential protein partners of cytoplasmic eEF1Bγ were linked to corneal diseases, particularly retinoblastoma (Kapustian et al., 2018; Kapustian et al., 2019). On the contrary, several possible partners of nuclear eEF1Bγ were involved to different neurodegenerative disorders (Kapustian et al., 2018; Kapustian et al., 2019). One cannot exclude that the specific localization of subunits may be associated with these diseases. The potential involvement of eEF1B in neurodevelopmental disorders was recently reviewed (McLachlan et al., 2019).
Conclusion
There are two recently emerging directions of eEF1B complex studies. These are: (i) exploring the molecular mechanisms and regulatory consequences of the appearance of its individual subunits under abnormal cellular conditions; (ii) studying the links of different intracellular localization of the eEF1B complex and/or its individual subunits to various non-translational processes and, possibly, diseases. Combination of these approaches should be of interest for upcoming investigators to couple fundamental eEF1B knowledge with its evolving clinical significance.
Author Contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Funding
A contribution of the Interdisciplinary program of scientific research “Molecular and cell biotechnologies for medicine, industry and agriculture” of National Academy of Sciences of Ukraine and the Ukraine State program “Supporting development of the priority directions of scientific research” (6541230) to the author’s lab research is greatly appreciated.
Conflict of Interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Bengsch, F., Tu, Z., Tang, H. Y., Zhu, H., Speicher, D. W., and Zhang, R. (2015). Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts. Cell Cycle 14, 1540–1547. doi: 10.1080/15384101.2015.1026492
Biterge-Sut, B. (2019). Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation. Life Sci. 238:116977. doi: 10.1016/j.lfs.2019.116977
Bondarchuk, T. V., Lozhko, D. M., Shalak, V. F., Fatalska, A., Szczepanowski, R. H., Dadlez, M., et al. (2019). The protein-binding N-terminal domain of human translation elongation factor 1Bβ possesses a dynamic α-helical structural organization. Int. J. Biol. Macromol. 126, 899–907. doi: 10.1016/j.ijbiomac.2018.12.220
Bondarchuk, T. V., Shalak, V. F., Negrutskii, B. S., and El’skaya, A. V. (2016). Leucine-zipper motif is responsible for self-association of translation elongation factor 1Bβ. Biopolym. Cell 32, 9–20. doi: 10.7124/bc.000907
Bresolin de Souza, K., Jutfelt, F., Kling, P., Förlin, L., and Sturve, J. (2014). Effects of increased CO2 on fish gill and plasma proteome. PLoS One 9:e102901. doi: 10.1371/journal.pone.0102901
Bruneel, A., Wendum, D., Labas, V., Mulner-Lorillon, O., Vinh, J., Bosselut, N., et al. (2011). Proteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα. Naunyn Schmiedebergs Arch. Pharmacol. 384, 407–419. doi: 10.1007/s00210-011-0639-5
Byun, H. O., Han, N. K., Lee, H. J., Kim, K. B., Ko, Y. G., Yoon, G., et al. (2009). Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. Cancer Res. 69, 4638–4647. doi: 10.1158/0008-5472.CAN-08-4042
Cao, Y., Portela, M., Janikiewicz, J., Doig, J., and Abbott, C. M. (2014). Characterisation of translation elongation factor eEF1B subunit expression in mammalian cells and tissues and co-localisation with eEF1A2. PLoS One 9:e114117. doi: 10.1371/journal.pone.0114117
Ceccon, M., Merlo, M. E. B., Mologni, L., Poggio, T., Varesio, L. M., Menotti, M., et al. (2016). Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Oncogene 35, 3854–3865. doi: 10.1038/onc.2015.456
Chen, L., Chen, W., Zhao, L., Yu, H. Z., and Li, X. (2009). Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen. World J. Urol. 27, 107–112. doi: 10.1007/s00345-008-0326-4
Cheng, D. D., Li, S. J., Zhu, B., Zhou, S. M., and Yang, Q. C. (2018). EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. J. Exp. Clin. Cancer Res. 37, 50. doi: 10.1186/s13046-018-0715-5
Cherkasov, V., Grousl, T., Theer, P., Vainshtein, Y., Glässer, C., Mongis, C., et al. (2015). Systemic control of protein synthesis through sequestration of translation and ribosome biogenesis factors during severe heat stress. FEBS Lett. 589, 3654–3664. doi: 10.1016/j.febslet.2015.10.010
Choudhary, I., Lee, H., Pyo, M. J., Heo, Y., Chae, J., Yum, S. S., et al. (2018). Proteomic Investigation to Identify Anticancer Targets of Nemopilema nomurai Jellyfish Venom in Human Hepatocarcinoma HepG2 Cells. Toxins 10:E194. doi: 10.3390/toxins10050194
de Wit, N. C., Heck, A. J., and Thornton, S. (2010). The effect of oxytocin and an oxytocin antagonist on the human myometrial proteome. Reprod. Sci. 17, 40–46. doi: 10.1177/1933719109345287
Dilworth, D., Gong, F., Miller, K., and Nelson, C. J. (2019). FKBP25 participates in DNA double-strand break repair. Biochem. Cell Biol. 98, 42–49. doi: 10.1139/bcb-2018-0328
Dilworth, D., Gudavicius, G., Xu, X., Boyce, A. K. J., O’Sullivan, C., Serpa, J. J., et al. (2018). The prolyl isomerase FKBP25 regulates microtubule polymerization impacting cell cycle progression and genomic stability. Nucleic Acids Res. 46, 2459–2478. doi: 10.1093/nar/gky008
Esposito, A. M., and Kinzy, T. G. (2010). The eukaryotic translation elongation Factor 1Bgamma has a non-guanine nucleotide exchange factor role in protein metabolism. J. Biol. Chem. 285, 37995–38004. doi: 10.1074/jbc.M110.160887
Fan, Y., Schlierf, M., Gaspar, A. C., Dreux, C., Kpebe, A., Chaney, L., et al. (2010). Drosophila translational elongation factor-1gamma is modified in response to DOA kinase activity and is essential for cellular viability. Genetics 184, 141–154. doi: 10.1534/genetics.109.109553
Flores, I. L., Kawahara, R., Miguel, M. C., Granato, D. C., Domingues, R. R., Macedo, C. C., et al. (2016). EEF1D modulates proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma. Clin. Sci. 130, 785–799. doi: 10.1042/CS20150646
Furukawa, R., Jinks, T. M., Tishgarten, T., Mazzawi, M., Morris, D. R., and Fechheimer, M. (2001). Elongation factor 1beta is an actin-binding protein. Biochim. Biophys. Acta 1527, 130–140.
Galat, A., Thai, R., and Stura, E. A. (2014). Diversified targets of FKBP25 and its complex with rapamycin. Int. J. Biol. Macromol. 69, 344–352. doi: 10.1016/j.ijbiomac.2014.05.060
Grousl, T., Ivanov, P., Malcova, I., Pompach, P., Frydlova, I., Slaba, R., et al. (2013). Heat shock-induced accumulation of translation elongation and termination factors precedes assembly of stress granules in S. cerevisiae. PLoS One 8:e57083. doi: 10.1371/journal.pone.0057083
Hagiwara, K., Katsuda, T., Gailhouste, L., Kosaka, N., and Ochiya, T. (2015). Commitment of Annexin A2 in recruitment of microRNAs into extracellular vesicles. FEBS Lett. 589, 4071–4078. doi: 10.1016/j.febslet.2015.11.036
Hassan, M. K., Kumar, D., Naik, M., and Dixit, M. (2018). The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers. PLoS One 13:e0191377. doi: 10.1371/journal.pone.0191377
IUBMB (1996). Prokaryotic and eukaryotic translation factors. Ad Hoc Nomenclature Subcommittee Report. Biochimie 78, 1119–1122.
Janssen, G., and Möller, W. (1988). Elongation factor 1 beta gamma from Artemia. Purification and properties of its subunits. Eur. J. Biochem. 171, 119–129.
Jeppesen, M. G., Ortiz, P., Shepard, W., Kinzy, T. G., Nyborg, J., and Andersen, G. R. (2003). The crystal structure of the glutathione S-transferase-like domain of elongation factor 1Bgamma from Saccharomyces cerevisiae. J. Biol. Chem. 278, 47190–47198.
Jia, L., Yang, T., Gu, X., Zhao, W., Tang, Q., Wang, X., et al. (2018). Translation elongation factor eEF1Bα is identified as a novel prognostic marker of gastric cancer. Int. J. Biol. Macromol. 126, 345–351. doi: 10.1016/j.ijbiomac.2018.12.126
Jiang, Y. L., Ning, Y., Ma, X. L., Liu, Y. Y., Wang, Y., Zhang, Z., et al. (2011). Alteration of the proteome profile of the pancreas in diabetic rats induced by streptozotocin. Int. J. Mol. Med. 28, 153–160. doi: 10.3892/ijmm.2011.696
Joseph, P., Lei, Y. X., Whong, W. Z., and Ong, T. M. (2002). Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene. J. Biol. Chem. 277, 6131–6136. doi: 10.1074/jbc.m109373200
Kamiie, K., Yamashita, T., Taira, H., Kidou, S., and Ejiri, S. (2003). Interaction between elongation factors 1beta and 1gamma from Bombyx mori silk gland. Biosci. Biotechnol. Biochem. 67, 1522–1529.
Kapustian, L. M., Dadlez, M., and Negrutskii, B. S. (2016). Non-canonical interactions of the β subunit of the translation elongation complex eEF1B and analysis of their possible functional role. Biopolym. Cell 32, 347–358. doi: 10.7124/bc.00092f
Kapustian, L. M., Dadlez, M., and Negrutskii, B. S. (2017). Protein partners of the eEF1Bβ subunit of the translation elongation complex eEF1B in the nuclear fraction of human lung carcinoma cells. Biopolym. Cell 33, 243–255. doi: 10.7124/bc.00095d
Kapustian, L. M., Lysetsky, I. L., Bondarchuk, T. V., Novosylna, O. V., and Negrutskii, B. S. (2018). Mass-spectrometric and bioinformatic analysis of eEF1Bγ interactome in the cytoplasmic fraction of A549 cells. Biopolym. Cell 34, 292–302. doi: 10.7124/bc.000982
Kapustian, L. M., Lysetsky, I. L., Bondarchuk, T. V., Novosylna, O. V., and Negrutskii, B. S. (2019). Analysis of eEF1Bγ interactome in the nuclear fraction of A549 human lung adenocarcinoma cells. Biopolym. Cell 35, 268–287. doi: 10.7124/bc.000a0a
Kim, S., Kellner, J., Lee, C. H., and Coulombe, P. A. (2007). Interaction between the keratin cytoskeleton and eEF1Bgamma affects protein synthesis in epithelial cells. Nat. Struct. Mol. Biol. 14, 982–983. doi: 10.1038/nsmb1301
Klopfleisch, R., Klose, P., Weise, C., Bondzio, A., Multhaup, G., Einspanier, R., et al. (2010). Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. J. Proteome Res. 9, 6380–6391. doi: 10.1021/pr100671c
Le Sourd, F., Boulben, S., Le Bouffant, R., Cormier, P., Morales, J., Belle, R., et al. (2006). eEF1B: At the dawn of the 21st century. Biochim. Biophys. Acta 1759, 13–31. doi: 10.1016/j.bbaexp.2006.02.003
Lei, Y. X., Chen, J. K., and Wu, Z. L. (2002). Blocking the translation elongation factor-1 delta with its antisense mRNA results in a significant reversal of its oncogenic potential. Teratog. Carcinog. Mutagen. 22, 377–383. doi: 10.1002/tcm.10034
Lei, Y. X., Wang, M., Wei, L., Lu, X., and Lin, H. Z. (2010). Alternative expression and sequence of human elongation factor-1 delta during malignant transformation of human bronchial epithelial cells induced by cadmium chloride. Biomed. Environ. Sci. 23, 151–157. doi: 10.1016/s0895-3988(10)60045-1
Li, D., Wei, T., Abbott, C. M., and Harrich, D. (2013). The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis. Microbiol. Mol. Biol. Rev. 77, 253–266. doi: 10.1128/MMBR.00059-12
Li, J., Feng, B., Nie, Y., Jiao, P., Lin, X., Huang, M., et al. (2018). Sucrose nonfermenting-related kinase regulates both adipose inflammation and energy homeostasis in mice and humans. Diabetes Metab. Res. Rev. 67, 400–411. doi: 10.2337/db17-0745
Liu, D., Sheng, C., Gao, S., Jiang, W., Li, J., Yao, C., et al. (2014). eEF1Bγ is a positive regulator of NF-êB signaling pathway. Biochem. Biophys. Res. Commun. 446, 523–528. doi: 10.1016/j.bbrc.2014.02.137
Liu, H., Han, Y., Mi, R., Zhang, Y., Su, G., Wang, H., et al. (2011). Identification of cervical cancer proteins associated with treatment with paclitaxel and cisplatin in patients. Int. J. Gynecol. Cancer 21, 1452–1457. doi: 10.1097/IGC.0b013e31822491d0
Liu, Y., Beyer, A., and Aebersold, R. (2016). On the dependency of cellular protein levels on mRNA abundance. Cell 165, 535–550. doi: 10.1016/j.cell.2016.03.014
Lu, Q., Lei, Y. X., He, C. C., and Lei, Z. N. (2013). Blood translation elongation factor-1δ is a novel marker for cadmium exposure. Int. J. Mol. Sci. 14, 5182–5197. doi: 10.3390/ijms14035182
McLachlan, F., Sires, A. M., and Abbott, C. M. (2019). The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. Hum. Mutat. 40, 131–141. doi: 10.1002/humu.23677
Mutlu, A., Ozturk, M., Akpinar, G., Kasap, M., and Kanli, A. (2017). Proteomics analysis of pleomorphic adenoma of the human parotid gland. Eur. Arch. Otorhinolaryngol. 274, 3183–3195. doi: 10.1007/s00405-017-4608-6
Novak, E. M., Lee, E. K., Innis, S. M., and Keller, B. O. (2009). Identification of novel protein targets regulated by maternal dietary fatty acid composition in neonatal rat liver. J. Proteomics 73, 41–49. doi: 10.1016/j.jprot.2009.07.008
O’Keeffe, G., Jöchl, C., Kavanagh, K., and Doyle, S. (2013). Extensive proteomic remodeling is induced by eukaryotic translation elongation factor 1Bγ deletion in Aspergillus fumigatus. Protein Sci. 22, 1612–1622. doi: 10.1002/pro.2367
Ong, L. L., Connie, P. N., Ho, A., Aung, M. T., and Yu, H. (2003). Kinectin anchors the translation elongation factor-1δ to the endoplasmic reticulum. J. Biol. Chem. 278, 32115–32123. doi: 10.1074/jbc.m210917200
Østergaard, L., Honoré, B., Thorsen, L. B., Baandrup, J., Eskildsen-Helmond, Y., Laursen, B. E., et al. (2011). Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in pulmonary hypertensive rats. Proteomics 11, 4492–4502. doi: 10.1002/pmic.201100171
Palacios, G., Shaw, T. I., Li, Y., Singh, R. K., Valentine, M., Sandlund, J. T., et al. (2017). Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex. Leukemia 31, 743–747. doi: 10.1038/leu.2016.331
Pérez, J. M., Siegal, G., Kriek, J., Hård, K., Dijk, J., Canters, G. W., et al. (1999). The solution structure of the guanine nucleotide exchange domain of human elongation factor 1beta reveals a striking resemblance to that of EF-Ts from Escherichia coli. Structure 7, 217–226. doi: 10.1016/s0969-2126(99)80027-6
Pisani, C., Onori, A., Gabanella, F., Delle Monache, F., Borreca, A., Ammassari-Teule, M., et al. (2016). eEF1Bγ binds the Che-1 and TP53 gene promoters and their transcripts. J. Exp. Clin. Cancer. Res. 35:146. doi: 10.1186/s13046-016-0424-x
Plant, E. P., Nguyen, P., Russ, J. R., Pittman, Y. R., Nguyen, T., Quesinberry, J. T., et al. (2007). Differentiating between near- and non-cognate codons in Saccharomyces cerevisiae. PLoS One 2:e517. doi: 10.1371/journal.pone.0000517
Puts, G. S., Leonard, M. K., Pamidimukkala, N. V., Snyder, D. E., and Kaetzel, D. M. (2018). Nuclear functions of NME proteins. Lab. Invest. 98, 211–218. doi: 10.1038/labinvest.2017.109
Sasikumar, A. N., Perez, W. B., and Kinzy, T. G. (2012). The many roles of the eukaryotic elongation factor 1 complex. Wiley Interdiscip. Rev. RNA 3, 543–555. doi: 10.1002/wrna.1118
Serpinskaya, A. S., Tuphile, K., Rabinow, L., and Gelfand, V. I. (2014). Protein kinase Darkener of apricot and its substrate EF1γ regulate organelle transport along microtubules. J. Cell Sci. 127, 33–39. doi: 10.1242/jcs.123885
Sheu, G. T., and Traugh, J. A. (1997). Recombinant subunits of mammalian elongation factor 1 expressed in Escherichia coli. Subunit interactions, elongation activity, and phosphorylation by protein kinase CKII. J. Biol. Chem. 272, 33290–33297. doi: 10.1074/jbc.272.52.33290
Shi, Y., Di Giammartino, D. C., Taylor, D., Sarkeshik, A., Rice, W. J., and Yates, J. R. III, et al. (2009). Molecular architecture of the human pre-mRNA 3’ processing complex. Mol. Cell 33, 365–376. doi: 10.1016/j.molceCl.2008.12.028
Takano, M., Otani, M., Kaji, T., Sano, K., Hamada-Kanazawa, M., and Matsuyama, S. (2016). Proteomic analysis of mouse choroid plexus cell line ECPC-4 treated with lipid A. Inflamm. Res. 65, 295–302. doi: 10.1007/s00011-016-0916-3
Trosiuk, T. V., Shalak, V. F., Szczepanowski, R. H., Negrutskii, B. S., and El’skaya, A. V. (2016). A non-catalytic N-terminal domain negatively influences the nucleotide exchange activity of translation elongation factor 1Bα. FEBS J. 283, 484–497. doi: 10.1111/febs.13599
Valouev, I. A., Fominov, G. V., Sokolova, E. E., Smirnov, V. N., and Ter-Avanesyan, M. D. (2009). Elongation factor eEF1B modulates functions of the release factors eRF1 and eRF3 and the efficiency of translation termination in yeast. BMC Mol. Biol. 10:60. doi: 10.1186/1471-2199-10-60
Vanwetswinkel, S., Kriek, J., Andersen, G. R., Güntert, P., Dijk, J., Canters, G. W., et al. (2003). Solution structure of the 162 residue C-terminal domain of human elongation factor 1Bgamma. J. Biol. Chem. 278, 43443–43451. doi: 10.1074/jbc.m306031200
Veremieva, M., Kapustian, L., Khoruzhenko, A., Zakharychev, V., Negrutskii, B., and El’skaya, A. (2014). Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer. BMC Cancer 14:913. doi: 10.1186/1471-2407-14-913
Veremieva, M., Khoruzhenko, A., Zaicev, S., Negrutskii, B., and El’skaya, A. (2011). Unbalanced expression of the translation complex eEF1 subunits in human cardioesophageal carcinoma. Eur. J. Clin. Invest. 41, 269–276. doi: 10.1111/j.1365-2362.2010.02404.x
Wallace, E. W., Kear-Scott, J. L., Pilipenko, E. V., Schwartz, M. H., Laskowski, P. R., Rojek, A. E., et al. (2015). Reversible, specific, active aggregates of endogenous proteins assemble upon heat stress. Cell 162, 1286–1298. doi: 10.1016/j.cell.2015.08.041
Wu, H., Shi, Y., Lin, Y., Qian, W., Yu, Y., and Huo, K. (2011). Eukaryotic translation elongation factor 1 delta inhibits the ubiquitin ligase activity of SIAH-1. Mol. Cell. Biochem. 357, 209–215. doi: 10.1007/s11010-011-0891-5
Wu, H., Wang, C., Gong, W., Wang, J., Xuan, J., Perrett, S., et al. (2016). The C-terminal region of human eukaryotic elongation factor 1Bδ. J. Biomol. NMR 64, 181–187. doi: 10.1007/s10858-016-0012-6
Xing, W., Gao, W., Su, H., Wang, S., Zhang, J., Mao, G., et al. (2018). Salidroside influences the cellular cross-talk of human fetal lung diploid fibroblasts: a proteomic approach. Environ. Toxicol. Pharmacol. 58, 114–121. doi: 10.1016/j.etap.2018.01.001
Xue, R., Peng, Y., Han, B., Li, X., Chen, Y., and Pei, H. (2019). Metastasis suppressor NME1 promotes non-homologous end joining of DNA double-strand breaks. DNA Repair 77, 27–35. doi: 10.1016/j.dnarep.2019.03.003
Yang, W., Shi, J., Zhou, Y., Liu, T., Li, J., Hong, F., et al. (2019). Co-expression network analysis identified key proteins in association with hepatic metastatic colorectal cancer. Proteomics Clin. Appl. 13:e1900017. doi: 10.1002/prca.201900017
Yin, P., Knolhoff, A. M., Rosenberg, H. J., Millet, L. J., Gillette, M. U., and Sweedler, J. V. (2012). Peptidomic analyses of mouse astrocytic cell lines and rat primary cultured astrocytes. J. Proteome Res. 11, 3965–3973. doi: 10.1021/pr201066t
Keywords: supramolecular complex, translation, elongation factors, eEF1B, intracellular localization, cancer, cytoplasm, nucleus
Citation: Negrutskii B (2020) Non-translational Connections of eEF1B in the Cytoplasm and Nucleus of Cancer Cells. Front. Mol. Biosci. 7:56. doi: 10.3389/fmolb.2020.00056
Received: 24 February 2020; Accepted: 20 March 2020;
Published: 09 April 2020.
Edited by:
Taku Kaitsuka, Kumamoto University, JapanReviewed by:
Ranen Aviner, Stanford University, United StatesYingang Feng, Qingdao Institute of Bioenergy and Bioprocess Technology (CAS), China
Copyright © 2020 Negrutskii. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Boris Negrutskii, negrutskii@imbg.org.ua